Clinical trials
Phase 2 Glucosephosphate Dehydrogenase Deficiency trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
4 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2013 | 1 |
| 2017 | 1 |
| 2018 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 4 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 1 |
| Fundação de Medicina Tropical Dr. Heitor Vieira Dourado | 1 |
| GlaxoSmithKline | 1 |
| InfaCare Pharmaceuticals Corporation, a Mallinckrodt Company | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Glucosephosphate Dehydrogenase Deficiency | 4 |
| Malaria, Vivax | 2 |
| Erythroblastosis, Fetal | 1 |
| Hematologic Diseases | 1 |
| Hyperbilirubinemia | 1 |
| Hyperbilirubinemia, Neonatal | 1 |
| Infant, Newborn, Diseases | 1 |
| Jaundice, Neonatal | 1 |
| Rare Diseases | 1 |
Trials
Showing 1 to 4 of 4. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.